| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership change | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-04-02 | Angulo Gonzalez David Chief Executive Officer | Purchase | +217,390 | +17.41%1,465,821 | N/A | N/A | View SEC filing | |
| 2024-09-16 | Angulo Gonzalez David Chief Executive Officer | Purchase | +20,000 | +4.10%507,871 | $1.37 | $27,400 | View SEC filing | |
| 2022-04-28 | Taglietti Marco Chief Executive Officer | Purchase | +75,000 | +38.06%272,068 | $3.00 | $225,000 | View SEC filing | |
| 2022-04-28 | Sukenick Scott General Counsel | Purchase | +3,500 | +7.00%53,499 | $3.00 | $10,500 | View SEC filing | |
| 2021-01-26 | EDELMAN JOSEPH 10% Owner | Sale | -599,000 | -25.00%1,800,000 | $7.86 | $4,705,431 | View SEC filing | |
| 2020-12-23 | Tinmouth Brian Philippe Director | Purchase | +8,000 | +100.00%8,000 | $6.25 | $50,000 | View SEC filing | |
| 2020-12-23 | Taglietti Marco Chief Executive Officer | Purchase | +40,000 | +57.42%109,668 | $6.25 | $250,000 | View SEC filing | |
| 2020-12-23 | Sukenick Scott General Counsel | Purchase | +1,600 | +21.34%9,099 | $6.25 | $10,000 | View SEC filing | |
| 2020-12-23 | Macdonald Guy Director | Purchase | +8,000 | +200.00%12,000 | $6.25 | $50,000 | View SEC filing | |
| 2020-12-23 | HANHAM ANN Director | Purchase | +3,200 | +758.29%3,622 | $6.25 | $20,000 | View SEC filing | |
| 2020-12-23 | GILMAN STEVEN C Director | Purchase | +4,000 | +100.00%4,000 | $6.25 | $25,000 | View SEC filing | |
| 2020-12-23 | Francois Eric Chief Financial Officer | Purchase | +600 | +5.39%11,732 | $6.25 | $3,750 | View SEC filing | |
| 2020-12-23 | ANIDO ARMANDO Director | Purchase | +5,000 | +100.00%5,000 | $6.25 | $31,250 | View SEC filing | |
| 2020-12-23 | Angulo Gonzalez David Chief Medical Officer | Purchase | +1,600 | +7.21%23,780 | $6.25 | $10,000 | View SEC filing | |
| 2019-12-16 | Taglietti Marco Chief Executive Officer | Purchase | +333,334 | +63.25%860,349 | $0.45 | $150,000 | View SEC filing | |
| 2019-08-22 | Taglietti Marco Chief Executive Officer | Purchase | +10,000 | +1.94%526,015 | $1.11 | $11,100 | View SEC filing | |
| 2019-08-19 | Taglietti Marco Chief Executive Officer | Purchase | +10,015 | +1.98%516,015 | $1.01 | $10,115 | View SEC filing | |
| 2019-04-18 | Taglietti Marco Chief Executive Officer | Purchase | +25,000 | +5.20%506,000 | $1.63 | $40,750 | View SEC filing | |
| 2019-01-14 | Taglietti Marco Chief Executive Officer | Purchase | +25,000 | +5.49%480,000 | $0.69 | $17,250 | View SEC filing | |
| 2019-01-02 | Taglietti Marco Chief Executive Officer | Purchase | +25,000 | +5.81%455,000 | $0.46 | $11,500 | View SEC filing | |
| 2019-01-02 | Angulo Gonzalez David Chief Medical Officer | Purchase | +12,000 | +10.93%121,790 | $0.50 | $5,951 | View SEC filing | |
| 2018-09-10 | Angulo Gonzalez David Chief Medical Officer | Purchase | +7,000 | +6.88%108,790 | $1.27 | $8,890 | View SEC filing | |
| 2018-08-27 | Taglietti Marco Chief Executive Officer | Purchase | +25,000 | +6.19%429,000 | $1.29 | $32,250 | View SEC filing | |
| 2018-04-02 | Angulo Gonzalez David Chief Medical Officer | Purchase | +6,000 | +6.26%101,790 | $1.36 | $8,160 | View SEC filing | |
| 2018-03-12 | Angulo Gonzalez David Chief Medical Officer | Purchase | +7,000 | +7.88%95,790 | $1.39 | $9,730 | View SEC filing |
1-25 of 61
